Medicines Optimisation & Therapy Review Service

Safe. Evidence-Based. ABPI-Compliant.
Contact UsExplore Training

About the Service

At CliniLink, we deliver clinically-led medicines optimisation services that support NHS primary care in achieving cost-effective, evidence-based prescribing. Our therapy review programmes are developed in partnership with GP practices, PCNs, and ICBs, and are aligned with local formularies and national guidelines.

Services are available via direct NHS commissioning or can be supported through unrestricted educational grants from the pharmaceutical industry, fully aligned with the ABPI Code of Practice. All reviews are conducted within NHS systems using DSP Toolkit-compliant platforms, with no patient-identifiable data extracted. Our team operates under robust governance, GDPR compliance, and NHS-approved data-sharing agreements.

Each programme is designed to improve prescribing quality, reduce clinical risk, and deliver lasting improvements in care, supported by training to embed change sustainably within local pharmacy teams.

Our Strategy

  • Secure remote access via DSP Toolkit-compliant platforms integrated with EMIS Web or SystmOne

  • In-house clinical pharmacists and prescribers with full employment checks and indemnity cover

  • Fully ABPI, GDPR, and IG-compliant operations

  • Structured outcome reporting with measurable clinical and financial impact

  • Linked training and mentoring to support workforce development and sustainability

Therapeutic Review Areas

We support therapy reviews across a range of high-priority clinical areas, including but not limited to:

  • Cardiovascular reviews – including atrial fibrillation, lipid management, and hypertension

  • Diabetes care – including appropriate prescribing of blood glucose testing strips and pen needles

  • Women’s health

  • Respiratory care

  • Dry eye disease

  • Pain management

  • Continence prescribing

  • Bone health

  • Fraility Reviews
  • Dermatology Reviews

  • Oral Nutritional Supplements

Our therapy review services aim to improve prescribing safety and efficiency, increase patient access to appropriate treatment, reduce unwarranted variation, and deliver measurable cost savings—while empowering local GP and pharmacy teams through clinical training and mentoring. All services are delivered in full alignment with NHS governance standards and the ABPI Code of Practice.

NICE 2026 Diabetes Guideline Update: New First-Line Prescribing Changes

The National Institute for Health and Care Excellence (NICE) has released a major update to NG28, the guideline for the management of type 2 diabetes in adults. This is the most significant shift in prescribing strategy since the original guideline was introduced. The...

COPD Case Study: Acute Exacerbation Management for Healthcare Professionals

If you found this article useful, don’t miss our upcoming CliniLink Respiratory Clinical Excellence Update  a live CPD-accredited event where experts will cover the latest COPD and asthma guidelines, FeNO in diagnosis, greener inhaler pathways, and practical...

Case Study: Diagnosing Heart Failure in Primary Care

Heart failure is not always obvious. A subtle rise in NT-proBNP or a patient who “just feels tired” can easily be misattributed to age or comorbidity.This short case highlights how structured interpretation of investigations — aligned with NICE NG106 (2024) and the...

A Complete Guide to AIR and MART Therapy for Asthma Control

Experience a new era in asthma care with our innovative combination inhalers that simplify treatment and enhance control. Learn more about asthma management at the NICE Guidelines.Combines prevention and relief in one inhaler, reducing the need for multiple...

Menopause CPD 2025: Event Highlights and Learning Outcomes for Prescribers

You know menopause can feel like a complex puzzle with missing pieces. On 27th September, over 100 delegates gathered to uncover valuable insights at our Menopause event with Dr Manju Navani and Dr Almas Agha. The focus was clear: equip you with a menopause toolkit to...

Expert Insights: Enhancing CVD Management in Primary Care Event

Imagine transforming your approach to CVD management with insights from two leading experts. At our 6th September event, Dr Aseem Mishra and Prof Ahmet Fuat delved into hypertension, chronic kidney disease, heart failure, and lipid management. The day wasn't just...

Deep Dive: Diabetes Management in Primary Care – CPD Event Recap

On Saturday 12th July 2025, CliniLink proudly hosted a face-to-face CPD-accredited event titled “Deep Dive: Diabetes Management in Primary Care,” and what a fantastic day it was! Held at the beautiful Royal Nawaab Pyramid venue in Stockport, the session welcomed over...

Amiloride vs Spironolactone in Resistant Hypertension: A Promising Alternative or Just Non-Inferior?

Resistant hypertension remains a persistent challenge in primary care and specialist settings alike. Despite guideline-directed therapy with ACE inhibitors or ARBs, calcium channel blockers, and thiazide-like diuretics, many patients continue to have suboptimal blood...

QR4: A Smarter Way to Predict Cardiovascular Risk

Cardiovascular disease (CVD) continues to be the leading cause of death in the UK and globally, despite decades of public health advances and improvements in treatment. As clinicians, our ability to accurately assess risk is central to preventing serious...

NICE AI Skin Cancer Guidance: What GPs Need to Know About New Referral Tools

The integration of artificial intelligence (AI) into primary care is no longer a futuristic concept—it’s here. With the recent NICE early value assessment (HTE24) guidance focusing on AI for assessing and triaging suspicious skin lesions, GPs are now at the forefront...